ZA824622B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA824622B
ZA824622B ZA824622A ZA824622A ZA824622B ZA 824622 B ZA824622 B ZA 824622B ZA 824622 A ZA824622 A ZA 824622A ZA 824622 A ZA824622 A ZA 824622A ZA 824622 B ZA824622 B ZA 824622B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA824622A
Other languages
English (en)
Inventor
R Todd
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of ZA824622B publication Critical patent/ZA824622B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA824622A 1981-07-10 1982-06-29 Pharmaceutical compositions ZA824622B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8121315 1981-07-10

Publications (1)

Publication Number Publication Date
ZA824622B true ZA824622B (en) 1983-04-27

Family

ID=10523154

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA824622A ZA824622B (en) 1981-07-10 1982-06-29 Pharmaceutical compositions

Country Status (5)

Country Link
EP (1) EP0069600A3 (de)
JP (1) JPS5810519A (de)
AU (1) AU8533582A (de)
GB (1) GB2100985A (de)
ZA (1) ZA824622B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
JP2835741B2 (ja) * 1989-04-10 1998-12-14 コニカ株式会社 枚葉カード類の樹脂ラミネート方法
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
AU685741B2 (en) * 1992-12-04 1998-01-29 Mayor Pharmaceutical Laboratories, Inc. Sprayable analgesic composition and method of use
US5552406A (en) * 1994-06-17 1996-09-03 The Mclean Hospital Corporation Method for treating pain and brain perfusion abnormalities using mixed opioid agonist-antagonists
US6264974B1 (en) 1998-07-07 2001-07-24 Salvagnini Italia Spa Buccal and sublingual administration of physostigmine
AU781537B2 (en) * 1998-12-18 2005-05-26 Palladin Healthcare International, Ltd. Composition for treatment of burns
DE19907328C2 (de) * 1999-02-20 2002-10-24 Johannes Reichardt Verfahren und System zur visuellen Programmierung
PT2561860T (pt) 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
EP1610791B1 (de) 2003-03-31 2011-02-23 Titan Pharmaceuticals, Inc. Polymeres implantat zur verzögerten freisetzung von dopamin antagonisten
NZ568313A (en) * 2005-11-21 2011-11-25 Schering Plough Ltd Pharmaceutical compositions comprising buprenorphine
MX2009000745A (es) 2006-07-21 2009-04-16 Biodelivery Sciences Int Inc Dispositivos de suministro transmucosa con admision mejorada.
GB2461681A (en) * 2008-04-17 2010-01-13 Pharmasol Ltd Buprenorphine liquid spray formulation with solvent and antioxidant
WO2010072398A2 (en) * 2008-12-22 2010-07-01 Boehringer Ingelheim Limited Veterinary formulations
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
GB2481728B (en) * 2010-06-30 2012-05-23 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
HRP20211539T1 (hr) * 2011-09-19 2021-12-24 Orexo Ab Sublingvalne tablete otporne na zloupotrebu koje sadrže buprenorfin i nalokson
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
GB2487007B (en) * 2012-03-19 2013-06-05 Londonpharma Ltd COC containers and delivery devices for the sublingual administration of opioids
KR102660711B1 (ko) * 2017-10-20 2024-04-26 키에시 파르마슈티시 엣스. 피. 에이. 활성 성분으로서 오피오이드 수용체 효능제를 포함하는 약제학적 제제, 그의 제조 방법 및 치료적 사용
ES2965836T3 (es) * 2018-01-22 2024-04-17 Foresee Pharmaceuticals Co Ltd Composición farmacéutica para administración de liberación mantenida de buprenorfina
BR112021019901A2 (pt) * 2019-04-18 2022-02-15 Chiesi Farm Spa Método para tratar síndrome de abstinência neonatal devido à retirada de opioides

Also Published As

Publication number Publication date
AU8533582A (en) 1984-01-12
EP0069600A3 (de) 1984-04-04
JPS5810519A (ja) 1983-01-21
GB2100985A (en) 1983-01-12
EP0069600A2 (de) 1983-01-12

Similar Documents

Publication Publication Date Title
PH25637A (en) Dipyridamole-containing pharmaceutical form
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
ZA824622B (en) Pharmaceutical compositions
NZ201520A (en) Substituted aminopyridazines and pharmaceutical compositions
ZA825397B (en) Pharmaceutical compositions
ZA81136B (en) Pharmaceutical compositions
ZA822856B (en) Pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8324133D0 (en) Pharmaceutical compositions
ZA82652B (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
DE3377696D1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
PT73952A (en) Pharmaceutical compositions
ZW18582A1 (en) Pharmaceutical compositions
KE3739A (en) Pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
ZA82186B (en) Pharmaceutical compositions
GB8331068D0 (en) Pharmaceutical compositions